Terms: = Sarcomas AND CD52, CDW52, EDDM5 AND Prognosis
1 results:
1. Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab.
Shukla N; Kobos R; Renaud T; Teruya-Feldstein J; Price A; McAllister-Lucas L; Steinherz P
Cancer; 2012 Aug; 118(15):3719-24. PubMed ID: 22170006
[TBL] [Abstract] [Full Text] [Related]
